| Original language | English |
|---|---|
| Pages (from-to) | 61 |
| Number of pages | 1 |
| Journal | AJOB Primary Research |
| Volume | 3 |
| Issue number | 1 |
| DOIs |
|
| State | Published - Jan 2012 |
Access to Document
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: AJOB Primary Research, Vol. 3, No. 1, 01.2012, p. 61.
Research output: Contribution to journal › Comment/debate
TY - JOUR
T1 - Erratum to
T2 - Participants Perceptions of Deep Brain Stimulation Research for Treatment-ResistantDepression: Risks, Benefits, and Therapeutic Misconception (AJOB Primary Research, 2, 4, (33-41))
AU - Leykin, Yan
AU - Christopher, Paul P.
AU - Holtzheimer, Paul E.
AU - Appelbaum, Paul S.
AU - Mayberg, Helen S.
AU - Lisanby, Sarah H.
AU - Dunn, Laura B.
N1 - Funding Information: In the article “Participants’ Perceptions of Deep Brain Stimulation Research for Treatment-Resistant Depression: Risks, Benefits, and Therapeutic Misconception,” by Yan Leykin, Paul P. Christopher, Paul E. Holtzheimer, Paul S. Appel-baum, Helen S. Mayberg, Sarah H. Lisanby, and Laura B. Dunn, published in AJOB Primary Research, Volume 2, Issue 4, pp. 33–41, the funding source for the article was not listed. The correct listing is as follows: This study was funded by the Greenwall Foundation (PI: Dunn). DBS studies at Emory were funded by grants from the Woodruff Fund, Stanley Medical Research Institute, the Dana Foundation and Emory Healthcare and performed under FDA IDE: G060028 and Clinicaltrials.gov ID#: NCT00367003. The DBS research devices were donated by St Jude Medical, Inc. DBS studies at Columbia were funded by St Jude Medical, Inc.
PY - 2012/1
Y1 - 2012/1
UR - https://www.scopus.com/pages/publications/84857214790
U2 - 10.1080/21507716.2012.649601
DO - 10.1080/21507716.2012.649601
M3 - Comment/debate
AN - SCOPUS:84857214790
SN - 2150-7716
VL - 3
SP - 61
JO - AJOB Primary Research
JF - AJOB Primary Research
IS - 1
ER -